Delivery Order SPE2DB20D1109-SPE2DB24FP43S

Award Date 7/2/24
Potential Completion Date 7/3/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,056.37 Firm Fixed Price Delivery Order contract is for the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication. The award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,656.98, is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of November 24, 2023. It is not associated with a set-aside designation. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,799.30, is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November...
This federal contract award, valued at $2,251.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Icosapent Ethyl 1 Gram Capsule 120s, a cardiovascular medication. The award is a Firm Fixed Price Delivery Order that does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication. The contract has a ceiling value of $1,468.09 and runs through February 2025. This award appears to be part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $1,248.14, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order (DO) for the supply of Icosapent Ethyl 1 gram capsules. The contract is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which runs through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,657.92 Firm Fixed Price Delivery Order is for the supply of Icosapent Ethyl 1 gram capsules, a prescription medication, with a period of performance through August 16, 2024. The award is not associated with a set-aside program. As a significant federal contractor, Amerisourcebergen provides a wide range of pharmaceutical products and medical...
This federal contract award is for the delivery of Icosapent Ethyl 1 gram capsules to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $1,904.24 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 7, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $3,115.61 firm fixed price delivery order is for the supply of 120-count bottles of the pharmaceutical product Icosapent Ethyl 1 gram capsules. The award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corporation with DLA,...
This federal contract award, with an ID of SPE2DX15D3014|SPE2DX24FXCHH, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,372.81, is for the delivery of Icosapent Ethyl 1 Gram Capsule 120s, a pharmaceutical product. The award is not designated with a set-aside, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP43S
    Delivery Order

This federal contract award, valued at $1,232.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates Amerisourcebergen's role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, through its extensive supply chain and distribution capabilities.

Generated 2/27/25, 12:41 PM